Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (21-30 of 902) with videos related to

Pageof 91
Sort By:
American Journal of Hematology|July 19, 2012
POEMS syndrome: update on diagnosis, risk-stratification, and managementAngela Dispenzieri
The New England Journal of Medicine|June 17, 2005
Bortezomib for myeloma -- much ado about somethingAngela Dispenzieri
Hematology. American Society of Hematology. Education Program|December 4, 2020
Monoclonal gammopathies of clinical significanceAngela Dispenzieri
Blood|May 2, 2012
How I treat POEMS syndromeAngela Dispenzieri
American Journal of Hematology|April 24, 2019
POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and managementAngela Dispenzieri
Blood Reviews|September 14, 2007
POEMS syndromeAngela Dispenzieri
Blood|February 14, 2018
Opening a can of worms in AL progressionAngela Dispenzieri
Blood|October 11, 2014
Renal risk and response in amyloidosisAngela Dispenzieri
Hematological Oncology|June 15, 2025
Lecture 4. Clonal Plasma Cell PrecursorsAngela Dispenzieri
Blood|November 20, 2025
Isatuximab: surface strike, deep response in AL amyloidosisEli Muchtar, Angela Dispenzieri
Pageof 91

Showing results (21-30 of 902) with videos related to

Sort By:
Pageof 91
American Journal of Hematology|July 19, 2012
POEMS syndrome: update on diagnosis, risk-stratification, and managementAngela Dispenzieri
The New England Journal of Medicine|June 17, 2005
Bortezomib for myeloma -- much ado about somethingAngela Dispenzieri
Hematology. American Society of Hematology. Education Program|December 4, 2020
Monoclonal gammopathies of clinical significanceAngela Dispenzieri
Blood|May 2, 2012
How I treat POEMS syndromeAngela Dispenzieri
American Journal of Hematology|April 24, 2019
POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and managementAngela Dispenzieri
Blood Reviews|September 14, 2007
POEMS syndromeAngela Dispenzieri
Blood|February 14, 2018
Opening a can of worms in AL progressionAngela Dispenzieri
Blood|October 11, 2014
Renal risk and response in amyloidosisAngela Dispenzieri
Hematological Oncology|June 15, 2025
Lecture 4. Clonal Plasma Cell PrecursorsAngela Dispenzieri
Blood|November 20, 2025
Isatuximab: surface strike, deep response in AL amyloidosisEli Muchtar, Angela Dispenzieri
Pageof 91